Regeneron Pharmaceuticals Inc. buy Piper Sandler
Start price
23.08.24
/
50%
€1,072.0
Target price
23.08.25
€1,109.7
Performance (%)
-53.25%
End price
24.08.25
€501.20
Summary
This prediction ended on 24.08.25 with a price of €501.20. Massive losses of -53.25% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €2.60 are taken into consideration when calculating the performance. Piper_Sandler has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -2.512% | -2.512% | 16.822% |
| iShares Core DAX® | -1,34 % | 1,40 % | 2,62 % |
| iShares Nasdaq 100 | -2,99 % | 2,18 % | 33,89 % |
| iShares Nikkei 225® | -2,90 % | 4,32 % | 53,00 % |
| iShares S&P 500 | -2,32 % | 1,48 % | 22,86 % |
Comments by Piper_Sandler for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at Piper Sandler from $1,166.00 to $1,242.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€666.40
31.03.26
31.03.26
€762.30
31.03.27
31.03.27
-20.66%
11.06.26
11.06.26
Stopped prediction by Piper_Sandler for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€538.80
18.05.26
18.05.26
€735.81
18.05.27
18.05.27
-1.87%
11.06.26
11.06.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€652.60
27.01.25
27.01.25
€964.27
27.01.26
27.01.26
-1.93%
28.01.26
28.01.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€780.20
01.11.24
01.11.24
€1,099.4
01.11.25
01.11.25
-27.20%
02.11.25
02.11.25